← Evidence map

ArticleClinical parkinsonism & related disorders2021

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.

Mark F Lew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

3 trials

NCT00257660phase 3116 enrolled2005 NCT00288509phase 3108 enrolled2006 NCT01753310phase 3134 enrolled2013

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions. | OpenQuestion